Literature DB >> 23281985

Antiretroviral preexposure prophylaxis for HIV prevention.

Michael C Thigpen, Charles E Rose, Lynn A Paxton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23281985     DOI： 10.1056/NEJMc1210464

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?

Authors:  Kenneth H Mayer; Douglas S Krakower
Journal:  Clin Infect Dis       Date:  2016-08-23       Impact factor: 9.079

2.  Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?

Authors:  Douglas S Krakower; Kenneth H Mayer
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

3.  Risk Factors Associated with Loss to Follow-up Among Transgender Women Receiving HIV Pre-exposure Prophylaxis in Chiang Mai province, Thailand.

Authors:  Natthapat Thongsak; Natthaporn Manojai; Rathawit Apiputhipan; Nicha Rongram; Natnita Mattawanon; Walaithip Bunyatisai; Bandhita Plubin; Nawapon Nakharutai; Salinee Thumronglaohapun; Pimwarat Srikummoon; Kanokkan Wongsawat; Patrinee Traisathit; Nontiya Homkham
Journal:  AIDS Behav       Date:  2022-08-05

4.  Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians.

Authors:  Oliver Bacon; Rafael Gonzalez; Erin Andrew; Michael B Potter; James R Iñiguez; Stephanie E Cohen; Albert Y Liu; Jonathan D Fuchs
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

5.  Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters.

Authors:  Douglas S Krakower; Kevin M Maloney; Chris Grasso; Katherine Melbourne; Kenneth H Mayer
Journal:  J Int AIDS Soc       Date:  2016-10-11       Impact factor: 5.396

6.  Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada.

Authors:  Zoë R Greenwald; Mathieu Maheu-Giroux; Jason Szabo; Judith Alexia B Robin; Michel Boissonnault; Vinh-Kim Nguyen; Réjean Thomas
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

7.  An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study.

Authors:  Noah Kiwanuka; Juliet Mpendo; Annet Nalutaaya; Matthias Wambuzi; Annet Nanvubya; Paul K Kitandwe; Enoch Muyanja; Julius Ssempiira; Apolo Balyegisawa; Ali Ssetaala
Journal:  BMC Public Health       Date:  2014-09-22       Impact factor: 3.295
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.